Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Parallel-group, Double-blind, Placebo Controlled, Multi-center Study to Assess the Efficacy and Safety of Different Doses of BAY1002670 in Subjects With Uterine Fibroids Over 3 Months

Next Previous
Search
Trial Profile

A Randomized, Parallel-group, Double-blind, Placebo Controlled, Multi-center Study to Assess the Efficacy and Safety of Different Doses of BAY1002670 in Subjects With Uterine Fibroids Over 3 Months

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 12 Dec 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Vilaprisan (Primary)
  • Indications Uterine leiomyoma
  • Focus Therapeutic Use
  • Acronyms ASTEROID 1
  • Sponsors Bayer

    • Most Recent Events

    • 30 Jul 2021 Results assessing exposure response modelling and simulation data of vilaprisan efficacy by using data from phase I and 2 studies including this study published in the British Journal of Clinical Pharmacology
    • 06 Dec 2018 Results published in the Fertility and Sterility
    • 10 Oct 2018 Results of an integrated analysis of ASTEROID 1 and 2 studies aimed to assess the efficacy and safety of vilaprisan in women with uterine fibroids using an extended patient dataset, presented at the American Society for Reproductive Medicine Scientific Congress 2018

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top